diphenhydramine hydrochloride

Generic: diphenhydramine hydrochloride

Labeler: hf acquisition co llc, dba healthfirst
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name diphenhydramine hydrochloride
Generic Name diphenhydramine hydrochloride
Labeler hf acquisition co llc, dba healthfirst
Dosage Form INJECTION, SOLUTION
Routes
INTRAMUSCULAR INTRAVENOUS
Active Ingredients

diphenhydramine hydrochloride 50 mg/mL

Manufacturer
HF Acquisition Co LLC, DBA HealthFirst

Identifiers & Regulatory

Product NDC 51662-1348
Product ID 51662-1348_ef7bd6e6-d62c-7e93-e053-2a95a90aef83
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA040466
Listing Expiration 2026-12-31
Marketing Start 2018-11-26

Pharmacologic Class

Classes
histamine h1 receptor antagonists [moa] histamine-1 receptor antagonist [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 516621348
Hyphenated Format 51662-1348

Supplemental Identifiers

RxCUI
1723740
UNII
TC2D6JAD40

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name diphenhydramine hydrochloride (source: ndc)
Generic Name diphenhydramine hydrochloride (source: ndc)
Application Number ANDA040466 (source: ndc)
Routes
INTRAMUSCULAR INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • 50 mg/mL
source: ndc
Packaging
  • 1 mL in 1 VIAL (51662-1348-1)
source: ndc

Packages (1)

Ingredients (1)

diphenhydramine hydrochloride (50 mg/mL)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["INTRAMUSCULAR", "INTRAVENOUS"], "spl_id": "ef7bd6e6-d62c-7e93-e053-2a95a90aef83", "openfda": {"unii": ["TC2D6JAD40"], "rxcui": ["1723740"], "spl_set_id": ["7b9ed8ef-ce21-19e7-e053-2a91aa0a81be"], "manufacturer_name": ["HF Acquisition Co LLC, DBA HealthFirst"]}, "finished": true, "packaging": [{"sample": false, "description": "1 mL in 1 VIAL (51662-1348-1)", "package_ndc": "51662-1348-1", "marketing_start_date": "20181126"}], "brand_name": "DIPHENHYDRAMINE HYDROCHLORIDE", "product_id": "51662-1348_ef7bd6e6-d62c-7e93-e053-2a95a90aef83", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Histamine H1 Receptor Antagonists [MoA]", "Histamine-1 Receptor Antagonist [EPC]"], "product_ndc": "51662-1348", "generic_name": "DIPHENHYDRAMINE HYDROCHLORIDE", "labeler_name": "HF Acquisition Co LLC, DBA HealthFirst", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "DIPHENHYDRAMINE HYDROCHLORIDE", "active_ingredients": [{"name": "DIPHENHYDRAMINE HYDROCHLORIDE", "strength": "50 mg/mL"}], "application_number": "ANDA040466", "marketing_category": "ANDA", "marketing_start_date": "20181126", "listing_expiration_date": "20261231"}